How was your experience with Chlormezanone?

First, a little about yourself

Tell us about yourself in a few words?

What tips would you provide a friend before taking Chlormezanone?

What are you taking Chlormezanone for?

Choose one
  • Other
  • Anxiety Disorders
  • Muscle Spasticity

How long have you been taking it?

Choose one
  • Less than a week
  • A couple weeks
  • A month or so
  • A few months
  • A year or so
  • Two years or more

How well did Chlormezanone work for you?

Did you experience many side effects while taking this drug?

How likely would you be to recommend Chlormezanone to a friend?

Uses of Chlormezanone


Chlormezanone is used in the treatment of:

  • Anxiety Disorders
  • Muscle Spasticity

This medication may be prescribed for other uses. Ask your doctor or pharmacist for more information.

Chlormezanone Brand Names

Chlormezanone may be found in some form under the following brand names:

Chlormezanone Drug Class

Chlormezanone is part of the drug class:

Chlormezanone Interactions

This is not a complete list of Chlormezanonedrug interactions. Ask your doctor or pharmacist for more information.

Chlormezanone Dosage

Take chlormezanone exactly as prescribed by your doctor. Follow the directions on your prescription label carefully.

The Chlormezanone dose your doctor recommends will be based on the following (use any or all that apply):

  • the condition being treated
  • other medical conditions you have
  • other medications you are taking
  • how you respond to this medication
  • your weight
  • your height
  • your age
  • your gender

Chlormezanone is available in the following doses:

  • Chlormezanone 100 Mg Oral Tablet
  • Chlormezanone 200 Mg Oral Tablet

Forms of Medication

Chlormezanone is available in the following forms:

  • Oral Tablet

All RxWiki content including health news, medication pages, and condition pages published prior to February 2023, was written and maintained by on-staff pharmacists. Please be advised that this content is no longer actively maintained and may now contain outdated information. If you have any questions regarding previously published content, please contact